LSX - The Network For Life Science Executives

16/11/2023

First 45 speakers confirmed for RNA Leaders Europe!

Taking place 13-14 March in Basel sessions continue to focus on scientific, clinical and commercial development of therapeutics and vaccines.

The show will begin with key sessions looking at investment, manufacturing and partnering.

What’s on the horizon for RNA investments as we venture into the next decade of RNA therapeutics and vaccines will be discussed by Ivan Burkov, Partner, INKEF Capital and Steven Biesmans, Principal, UCB.

The Bottlenecks in RNA Manufacturing will be addressed by Julie Anderson, Head of RNA Centre of Excellence, Centre for Process Innovation and Christopher Jewell, CSO, Cartesian Therapeutics.

What is takes for RNA partnerships of big pharma, biotech and industry providers to succeed will be reviewed by Paul Nioi, VP, Discovery & Translational Research, Alnylam Pharmaceuticals, Dee Datta, CEO, Switch Therapeutics and Ulrik Lytt Rahbek, VP of Partnerships RNA & Gene Therapies, Novo Nordisk.

You can see more speakers and the full agenda at
https://informaconnect.com/rna-leaders-europe/

06/09/2023

Great to be back in Boston for RNA Leaders USA!

We have an exciting day in store, packed with insightful talks, engaging interactive sessions, and valuable networking opportunities.

Find out more:https://www.lsxleaders.com/rna-leaders-usa-congress

14/08/2023

📣 Attention European Life Science Innovators! 🌍🧪

Nominations for the prestigious European Lifestars Awards (ELAs) 2023 are now OPEN! This is the opportunity to celebrate your breakthroughs and success stories! 🎉

Recognized as the largest celebration of European life science leadership, the ELAs will return on 13th November 2023 at London's esteemed City Garden @ Honourable Artillery Company venue. 🎊🥇

This year, 150 finalists from 18 countries across 5 geographic regions of Europe will compete in 17 award categories, presenting a remarkable chance to gain global exposure, win a category, and represent your region! 🏆🌍

Here's the best part, nominations are FREE, and it's a golden opportunity to:
✨ Increase regional and global exposure.
✨ Connect with new investors, strategic partners, and clients.
✨ Attract A-Grade talent.

Here are the categories in which your company can shine:

Seed Finance Raise of the Year
Series A Finance Raise of the Year
Series B Finance Raise of the Year
Series C (& beyond) Finance Raise of the Year
IPO of the Year
Post-IPO Equity Raise of the Year
Venture Capital Firm of the Year
Deal of the Year (€500m)
M&A Deal of the Year
Pharma BD Team of the Year
Biotech Company of the Year
Medtech Company of the Year
Healthtech Company of the Year
Women-Led Business Leader of the Year
Private Company CEO of the Year
Public Company CEO of the Year

Make your mark in European life sciences, contribute to your region's success and help us celebrate the amazing accomplishments in the industry. 🌟

For more information on the process, ceremony, finalist benefits, judging faculty, and much more, check out the website - https://lnkd.in/g-k5fms

Nominate now! Let's celebrate success together! 🚀https://lnkd.in/g3mSeG4

28/06/2023

The LSX Nordic Congress brings unmatched opportunities to connect, collaborate, and form lasting relationships with key industry leaders and innovators from across the Nordic region, as well as international life science executives and active investors!

This year's agenda focuses on partnering, strategy & investment across the Nordic life science ecosystem with 90+ speakers already confirmed including global BD heads at AstraZeneca, Lundbeck, Zimmer Biomet and Roche and international investors Forbion, Sofinnova, Jeito Capital and Monograph Capital.

Secure the best rate, and book before 30 June to save up to DKK 4300.

Find out more - https://lnkd.in/dVJ_dy4

27/06/2023

📣 This year's LSX USA Congress is offering a not-to-be-missed chance to connect with 800+ international life sciences industry leaders and investors, all focused on accelerating growth and forming strategic partnerships.

Over the course of the two days, LSX USA Congress is set to serve as a launchpad for your growth and success. Get access to:

- Qualified 1:1 partnering: Pre-arrange private meetings with your preferred participants ahead of the event with our user-friendly conference partnering App. Search, filter, and auto-schedule to build your personal itinerary with ease

- Showcase: Pitch your company to active life science investors and deal makers. Raise your profile, source partners, and close your current funding round by presenting your business opportunity.

- Expert insights: Over 130 expert industry speakers and KOLs will share their insights and experiences, opening up an array of learning opportunities for you

- Workshops: Seize the opportunity to partake in our exclusive workshops covering Clinical Strategies, IP and IPO preparedness and strategy.

- CEO Forums: Engage in our unique, intimate forums tailored for CEOs. Exchange strategies, absorb learnings from intriguing case studies, and converse with your peers in a focused setting

Find out more - https://www.lsxleaders.com/lsx-usa-congress

05/05/2023

A massive thank you to all the attendees at this years LSX World Congress. An incredible two days of keynotes, sector tracks, showcases, forums, exhibition and a record number of 1-2-1 partnering meetings.

Thank you to our speakers, sponsors, delegates, supporters, long-time advocates of this event, and to our special royal guests during the networking reception. We couldn’t have done it without you all!

Save the dates 30 April - 1 May 2024.

It's our 10th anniversary and yes, there will be cake!

15/03/2023

We're thrilled to kick off 2023 with the newest addition to our portfolio: RNA Leaders.

This high-quality therapeutic conference focuses on presenting pre-clinical and clinical data from companies developing new RNA medicines.

We're excited return to Basel this week for our second year, where we'll be sharing the latest advancements in RNA therapeutics.

To learn more about the conference and what to expect, please visit: https://www.lsxleaders.com/rna-leaders-world-congress

14/02/2023

LSX connects life science executive decision makers with the capital, intelligence, innovation, and partners they need to grow their businesses and create the medicines of the future.

Join us in 2023 to Connect with Purpose - https://www.lsxleaders.com/

• RNA Leaders Europe, 15-16 March 2023, Switzerland - www.lsxleaders.com/rna
• Workforce Wellbeing Live, 20 April 2023, London, UK - www.lsxleaders.com/wellbeing
• LSX World Congress, 3-4 May 2023, London, UK - www.lsxleaders.com/london
• RNA Leaders USA, 6-7 September 2023, Boston, USA - www.lsxleaders.com/rnausa
• LSX USA Congress & CEO Forums, 13-14 September 2023, Boston, USA - www.lsxleaders.com/usa
• LSX Nordic Congress, 10-11 October 2023, Copenhagen, Denmark - www.lsxleaders.com/nordic
• Inv€$tival Showcase, 13 November 2023, London, UK - www.lsxleaders.com/investival
• European Lifestars Awards, 13 November 2023, London, UK - www.europeanlifestarsawards.com

LSX connects senior life science executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses

26/01/2022

Fantastic to bring you the latest speakers for the LSX World Congress 2022 taking us over 200!

Welcome:

• Elisa Petris, Partner, Syncona Limited
• Bernd Boidol, CEO, Proxygen
• Bibhash Mukhopadhyay, Founding Partner, Sound Bioventures
• Regina Hodits, Managing Partner, Wellington Partners
• Mike Alavarez, CEO, Qardio, Inc.
• Brian Heaphy, SVP, Head of Corporate Development, Strategy & Business Development, Bristol Myers Squibb
• Sofia Håkansson Buch, VP Stem Cell CMC & Manufacturing, Novo Nordisk
• Samih Al Mawass, Divisional VP EMEA Vascular, Abbott

Find out more at
https://bit.ly/3G9zc8M

The LSX World Congress connects biotech, medtech & healthtech executives with investors & the pharma industry through one-to-one partnering & high-level industry discussion.

23/12/2021

LSX World Congress 2022 has been postponed until May

After much careful consideration and consultation with our valued stakeholders, we’ve made the decision to postpone the LSX World Congress until May 10-11 2022.

You can read the full statement here
https://bit.ly/3ehyn1Z

Wishing you a very Happy Christmas and looking forward to working with you in the New Year.

08/12/2021

200+ life science investors you need to meet

Meet 200+ investor and strategics that have active mandates in investing and supporting life science and healthcare companies, from drug discovery / design to on-the-market, and everything in between.

For the purpose of this report we’ve aggregated and summarised the investment preferences of these firms and highlighted which therapeutic and technology areas are attracting the most attention right now.

Their contributions to the ongoing development of biotech, healthtech, medtech and deeptech companies in this region cannot be overlooked and, if you are not already connected with these firms, they should be on your radar.

These 200+ firms make up the present cohort of investor and strategic attendees to the 8th LSX World Congress taking place in-person across the 8-9 February, in London. Over 1000 delegates are expected.

Download the pdf report
https://bit.ly/306htjv

26/10/2021

Earlier this month Nestle debuted their less sugar chilled snack selection and Mission Barns secured the first partnership in North America between a plant-based meat manufacturer and cultivated fat provider to produce plant protein sausage with cultivated fat.

These are two great examples of how the food industry is trying to adapt to meet the evolving consumer.

Next month at the Food Biotech Congress we will have a forensic discussion about the market need for new ingredients and bioprocessing technologies in alternative Dairy, Meat, Seafood, Confectionary and Healthy Snacking.

Including exploring how consumer trends and behaviours are driving food ingredient developments and areas of growth to biotech based approaches.

Hear from:

• Austin Cloves, Fundraising and Science Lead, The Good Food Institute
• Josh Silverman, CEO, Aromyx Corporation
• Ahmed Khan, Founder, CellAgri
• Irina Gerry, CMO, Change Foods
• Moderator: Brian Chau, Food Systems Analyst, Chau Time

This session takes place as part of Food Biotech Congress spanning the week of 8-12 November with the main content sessions running live 10-11.

Find out more here → https://bit.ly/3Gr9EF8